Procedures for Gynecologic Specimen Collection
General Information for all Gynecologic Collections
The adequacy of the cervical screening specimen is determined by:
- The presence of an adequate squamous component.
- The presence of an adequate endocervical component (in premenopausal females with a cervix).
- The absence of obscuring entities, including inflammation, blood, and contaminants such as talc or lubricant.
- Adequate cellular preservation.
General patient instructions:
- In premenopausal patients, obtain specimens during the second half of the menstrual period to avoid contamination by obscuring blood. However, menstrual bleeding is not a contraindication to cervical screening. The problem of blood obscuring the cellular field is significantly reduced by the use of the liquid-based thin-layer specimen.
- The patient may be instructed not to douche or engage in sexual intercourse within 24 hours of the procedure. This may improve the cellular yield and reduce the potential for obscuring elements. Again, the use of the liquid-based, thin-layer specimen significantly reduces the potential for interference in the quality of the specimen.
General procedural instructions (see below for specific instructions)
- The cervical screening specimen should be collected prior to bimanual examination.
- Care should be taken to avoid contamination of the sample with lubricant jelly. The vaginal speculum should be inserted with warm water as a lubricant.
- Ideally the entire portion of cervix should be visible when the specimen is obtained.
- Vaginal discharge or secretion, when present in large amounts, should be removed before obtaining the cervical sample so as not to disturb the epithelium. Small amounts of blood will not interfere with cytologic evaluation; however, large amounts of blood as present during menses may interfere with cytologic interpretation because of obscuring blood. If the patient has no sign of symptoms of a cervical disorder, consideration may be given to treating the vaginitis first. Use of the thin layer specimen minimizes the interference from these factors.
- If testing for sexually transmitted disease is indicated, the cervical screening specimen should be taken first, followed by tests for gonococcus and chlamydia.
- Clinical history and findings are also very important for proper interpretation; for example: past history of dysplasia of cervix treated with laser, cryosurgery, LEEP, etc.; presence of cervix ectropion, polyp, etc.
- It is extremely important to enter all information on the cytology request form. This includes age of the patient, date of last menstrual period, pre- or postmenopausal status, use of and type of contraception, use of hormone replacement therapy (estrogen and progesterone), whether the patient received chemotherapy or radiation therapy.
SurePath™ Preparations
| Indications: | Cervical screening for the detection of premalignant or malignant lesions of the cervix which can be eradicated thus reducing the occurrence of invasive carcinoma of the cervix. The use of the thin-layer/liquid-based collection procedure is intended to replace the conventional Pap smear |
| Specimens Required: | Cervical sample from the junction of the ectocervix and the endocervix (transition zone). |
| Supplies: | SurePath®™ Preservative
Fluid Collection Vial Broom-type sampling device (Cervex-Brush™ )RECOMMENDED OR Brush Spatula |
| Collection Method: |
Properly fill out a Cytopathology Requisition with appropriate Patient demographics, pertinent clinical information, and relevant history, Label SurePath™ Preservative Fluid Collection Vial with correct patient name and medical record number. Collect a sample with a broom-type (Cervex-Brush™) sampling device using the following procedure: |
|
Reflexive HPV-DNA Testing on SurePath™ Specimens with ASCUS Diagnosis |
|
| Indications: | Human Papilloma Virus DNA (HPV-DNA) testing is available for those patients with the diagnosis of Atypical Squamous Cells of Undetermined Significance (ASCUS). Those patients in whom Atypical Squamous Cells of Undetermined Significance (ASCUS) are detected should have a HPV-DNA (Hybrid Capture 2) test performed. This test is most cost-effective when performed on the original liquid-based thin-layer specimen in which the ASCUS was identified. Patient management can then be based on an algorithm using the results of these combined tests. |
| Specimens Required: |
Liquid-Based Thin-Layer specimen |
| Supplies: | SurePath™ Preservative
Fluid Collection Vial Broom-type sampling device (Cervex-Brush™ ) Supplies may be obtained by calling Client Services at 1-866-869-1334. |
| Collection Method: |
|
Cytyc ThinPrep® Pap Preparations
| Indications: | Cervical screening for the detection of premalignant or malignant lesions of the cervix which can be eradicated thus reducing the occurrence of invasive carcinoma of the cervix. The use of the thin-layer/liquid-based collection procedure is intended to replace the conventional Pap smear. |
| Specimens Required: | Cervical sample from the junction of the ectocervix and the endocervix (transition zone). |
| Supplies: | Cytyc ThinPrep® PreservCyt Vial Broom-type sampling device OR Endocervical Brush/Spatula |
| Collection Method: |
Properly fill out a Cytopathology Requisition with appropriate Patient demographics, pertinent clinical information, and relevant history, Label ThinPrep PreservCytCollection Vial with correct patient name and medical record number. Collect a sample with a broom-type sampling device or endocervical brush/spatula using one of the following procedures: |
Broom-like Device Collection: Recommendation: Do not recommend using lubricant as it interferes with
the processing of the specimen and may result in an inadequate slide.
If lubricant has to be used in collection of specimen, suitable lubricants
include KY Jelly (non sterile or sterile), Surgilube, or Astroglide.
Other lubricants interfere with specimen and should not be used.
|
|
Recommendation: Do not recommend using lubricant as it interferes with the processing of the specimen and may result in an inadequate slide. If lubricant has to be used in collection of specimen, suitable lubricants include KY Jelly (non sterile or sterile), Surgilube, or Astroglide. Other lubricants interfere with specimen and should not be used.
|
Reflexive HPV-DNA Testing on ThinPREP® Specimens with ASCUS Diagnosis
| Indications: | Human Papilloma Virus DNA (HPV-DNA) testing is available for those patients with the diagnosis of Atypical Squamous Cells of Undetermined Significance (ASCUS). Those patients in whom Atypical Squamous Cells of Undetermined Significance (ASCUS) are detected should have a HPV-DNA (Hybrid Capture 2) test performed. This test is most cost-effective when performed on the original liquid-based thin-layer specimen in which the ASCUS was identified. Patient management can then be based on an algorithm using the results of these combined tests. |
| Specimens Required: |
Liquid-Based Thin-Layer specimen |
| Supplies: |
Cytyc
ThinPrep® PreservCyt Vial Broom-type sampling device OR Endocervical Brush/Spatula |
| Collection Method: | 1. Collect Thin-layer specimen for gynecologic cytology following
Thin-layer (ThinPrep®) Preparation collection method (see
above).
2. Select or provide handwritten instructions on the Cytology requisition for :"Thin-layer With Reflex HPV if ASCUS" (Recommended Standard of Care). HPV-DNA Testing results will appear as a Procedure/Addendum to the original Gynecologic Cytology Report when Reflexive HPV Testing is completed. |
Conventional Pap Smears
| Indications | Cervical screening for premalignant or malignant cervical lesions which can be eradicated to reduce the incidence of invasive cervical cancers. |
| Specimens Required: | Cervical and endocervical samples. |
| Supplies: | Vaginal speculum, wooden extended-tip spatula, cytobrush, fixative (spray fixative or 95% ethyl alcohol), clean glass slide (single end frosted), black lead lab pencil, request form. Spatulas, slides, fixative and slide mailers may be obtained from Client Services (1-800-695-6491). |
| Collection Procedure: |
|
| * The collected material should be applied uniformly to the slide, without clumping, and should be rapidly fixed to avoid air drying. If spray fixatives are used, the spray SHOULD BE HELD AT LEAST 10 INCHES AWAY from the slide to prevent dispersal and destruction of the cells by the propellant. |
OTHER COLLECTIONS:
DES Exposure Screening
| Indications: | Evaluation of potential changes associated with in utero DES exposure. |
| Specimens Required: | Right and left lateral vaginal, anterior vaginal, posterior vaginal, cervical sample. |
| Supplies: | Vaginal speculum, one or more cervical spatulas, one extended-tip spatula, cytobrush***, fixative (spray fixative or 95% ethyl alcohol), five clean glass slides (single-end frosted), black lead lab pencil, request form. SurePath Cytorich® Preservative Vial, broom sampling device (Cervex-Brush™), spatulas, slides, fixative and slide folders may be obtained from Client Services (1-800-695-6491). |
| Collection Procedure: | Label all slides with patient's name and specific site (anterior, posterior, right lateral, left lateral, cervical). Obtain specimens prior to bimanual examination. Use an unlubricated speculum (saline or warm water may be used). After visualization of the upper 1/3 of the vagina is accomplished, with the spatula scrape the upper 1/3 of either lateral vaginal wall. Withdraw the spatula and spread the material quickly and evenly onto the correctly labeled slide. Fix immediately (drop slide into fixative or spray with fixation, holding the spray bottle approximately 8 to 12 inches from the slide). Sample remaining specimen sites. Perform the cervical sample as described above using either the thin-layer or conventional smear technique. A liquid thin-layer screening is recommended for the cervical specimen. Smear and fix slides appropriately. Complete the cytology request form, including relevant history. Submit the specimen along with the request form. |
Vaginal Sampling
| Indications: | Vaginal sampling may be indicated in patients with prior history of cervical cancer or premalignant lesions which have been treated with hysterectomy and removal of the cervix. The vaginal cuff is the target of the sampling. |
| Specimens Required: | Liquid-based thin-layer specimen or conventional smear |
| Supplies: | Vaginal speculum, SurePath
CytoRich® Preservative Vial and Broom (Cervex-Brush™) Glass slide, cytobrush, spatula, and spray fixative. |
| Collection Procedure: |
|
*Alternatively the vaginal cuff can be brushed with the cytobrush and the specimen rolled onto the surface of a labeled glass slide. The slide should be spray fixed immediately and sent to the laboratory with the appropriate requisition. |